| 1. |
Koblí?ek V,Chlumsky J,Zindr V,et al.Chronic obstructive pulmonary disease in the light of new guidelines-brief summary of phenotypically oriented guidelines fornon pulmonary physicians.Vnitr Lek,2013,59:505-514.
|
| 2. |
Izquierdo-Alonso JL,Rodriguez-Gonzalezmoro JM,de Lucas-Ramos P,et al.Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease.Respir Med,2013,107:724-731.
|
| 3. |
Wedzicha JA,Brill SE,Allinson JP,et al.Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.BMC Med,[2013-8-14].http://www.biomedcentral.com/1741-7015/11/181.
|
| 4. |
Yawn BP.Early identification of exacerbations in patients with chronicobstructivepulmonarydisease.JPrimCareCommunityHealth,2013,4:75-80.
|
| 5. |
Miravitlles M,Soriano JB,Ancochea J,et al.Characterisation of the overlap COPD-asthma phenotype.Focus on physical activity and health status.Respir Med,2013,107:1053-1060.
|
| 6. |
Stockley RA.Bronchiectasis with chronic obstructive pulmonary disease:association or a further phenotype? Am J Respir Crit Care Med,2013,187:786-788.
|
| 7. |
Novosad SA,Barker AF.Chronic obstructive pulmonary disease and bronchiectasis. Curr Opin Pulm Med,2013,19:133-139.
|
| 8. |
Ogawa E,Nakano Y,Ohara T,et al.Body mass index in male patients with COPD:correlation with low attenuation areas on CT.Thorax,2009,64:20-25.
|
| 9. |
丁衛東,傅江濤,黃慶琳,等.阻塞性睡眠呼吸暫停低通氣綜合征并慢阻肺患者肺功能特點分析.中國現代醫生,2013,51:56-58.
|
| 10. |
Adir Y,Shachner R,Amir O,et al.Severe pulmonary hypertension associated with emphysema:a new phenotype.Chest,2012,142:1654-1658.
|
| 11. |
Matkovic Z,Miravitlles M.Chronic bronchial infection in COPD.Is there an infective phenotype.Respir Med,2013,107:10-22.
|
| 12. |
From the Global Strategy for the Diagnosis,Management and Prevention of COPD,Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011.
|
| 13. |
Kesten S,Celli B,Decramer M,et al.Adverse health consequences in COPD patients with rapid decline in FEV1 evidence from the UPLIFT trial.Respir Res,2011,12:129-131.
|
| 14. |
Nishinura M,Makita H,Nagai K,et al.Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2012,185:44-52.
|
| 15. |
Makita H.Annual decline of forced expiratory volume in 1sec (FEV1) over 4 years in COPD based on clinical phenotypes.Am J Respir Crit Care Med,2010,181:1534-1538.
|
| 16. |
Kim V,Pechulis RM,Abuel-Haija M,et al.Small airway pathology and bronchoreversibility in advanced emphysema.COPD,2010,7:93-101.
|
| 17. |
Lee JS,Huh JM,Chae EJ,et al.Different therapeutic responses in chronic obstructive pulmonary disease subgroups.Int J Tuberc Lung Dis,2011,15:1104-1110.
|
| 18. |
Kitaquchi Y, Fujimoto K,Kubo K,et al.Characteristics of COPD phenotypes classified according to the findings of HRCT.Respir Med,2006,100:1742-1752.
|
| 19. |
Mohamed Hoesein FA,Schmidt M,Mets OM,et al.Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD.Respir Med,2014,108:136-143.
|
| 20. |
Tulek B,Kivrak AS,Ozbek S,et al.Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography.Can Respir J,2013,20:91-96.
|
| 21. |
Holloway RA,Donnelly LE.Immunopathogenesis of chronic obstructive pulmonary disease.Curr Opin Pulm Med,2013,19:95-102.
|
| 22. |
Packard TA,Li QZ,Cosgrove GP,et al.COPD is associated with production of autoantibodies to a broad spectrum of self-antigens,correlative with disease phenotype.Immuno Res,2013,55:48-57.
|
| 23. |
Natanek SA,Gosker HR,Slot IG,et al.Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine? Muscle Nerve,2013,48:488-497.
|
| 24. |
Ryerson CJ,Hartman T,Elicker BM,et al.Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.Chest,2013,144:234-240.
|
1/5
WeChat